Andere Kunden interessierten sich auch für
![HIV Screening and Access to Care]( "HIV Screening and Access to Care")
HIV Screening and Access to Care33,99 €![HIV Screening and Access to Care]( "HIV Screening and Access to Care")
HIV Screening and Access to Care32,99 €![Improving Access to Hiv/AIDS Medicines in Africa: Trade-Related Aspects of Intellectual Property Rights Flexibilities]( "Improving Access to Hiv/AIDS Medicines in Africa: Trade-Related Aspects of Intellectual Property Rights Flexibilities")
Improving Access to Hiv/AIDS Medicines in Africa: Trade-Related Aspects of Intellectual Property Rights Flexibilities27,99 €![Monitoring HIV Care in the United States]( "Monitoring HIV Care in the United States")
Monitoring HIV Care in the United States68,99 €![Monitoring HIV Care in the United States]( "Monitoring HIV Care in the United States")
Monitoring HIV Care in the United States49,99 €![HIV and Disability]( "HIV and Disability")
HIV and Disability53,99 €![Strategic Approach to the Evaluation of Programs Implemented Under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against Hiv/Aids, Tuberculosis, and Malaria Reauthorization Act of 2008]( "Strategic Approach to the Evaluation of Programs Implemented Under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against Hiv/Aids, Tuberculosis, and Malaria Reauthorization Act of 2008")
Strategic Approach to the Evaluation of Programs Implemented Under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against Hiv/Aids, Tuberculosis, and Malaria Reauthorization Act of 200866,99 €
"With the widespread use of highly active anti-retroviral treatment (HAART), HIV has become a chronic, rather than a fatal, disease. But for their treatment to succeed, patients require uninterrupted care from a health care provider and uninterrupted access to anti-HIV medications. The IOM identifies federal, state, and private health insurance policies that inhibit HIV-positive individuals from initiating or continuing their care."--